Syed Ibrahim Rizvi

Syed Ibrahim Rizvi

Auto-generated profile, based on publicly available information

Syed Ibrahim Rizvi

Department of Biochemistry, Faculty of Science, University of Allahabad

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KPKanti Bhooshan Pandey
Kanti Bhooshan Pandey
SRSyed Ibrahim Rizvi
Syed Ibrahim Rizvi
Polyphenols are secondary metabolites of plants and are generally involved in defense against ultraviolet radiation or aggression by pathogens. In the last decade, there has been much interest in the potential health benefits of dietary plant polyphenols as antioxidant. Epidemiological studies and associated meta‐analyses strongly suggest that long term consumption of diets rich in plant polyphenols offer protection against development of cancers, cardiovascular diseases, diabetes, osteoporosis and neurodegenerative diseases. Here we present knowledge about the biological effects of plant polyphenols in the context of relevance to human health.

17 December 2013 in Journal of Biomarkers
Verified
Journal Article
Open access
PDF file
BTBrahm Kumar Tiwari
Brahm Kumar Tiwari
KPKanti Bhooshan Pandey
Kanti Bhooshan Pandey
AAA. B. Abidi
A. B. Abidi
SRSyed Ibrahim Rizvi
Syed Ibrahim Rizvi
The prevalence of diabetes mellitus is rising all over the world. Uncontrolled state of hyperglycemia due to defects in insulin secretion/action leads to a variety of complications including peripheral vascular diseases, nephropathy, neuropathy, retinopathy, morbidity, and/or mortality. Large body of evidence suggests major role of reactive oxygen species/oxidative stress in development and progression of diabetic complications. In the present paper, we have discussed the recent researches on the biomarkers of oxidative stress during type 2 diabetes mellitus.

30 October 2009 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
KPKanti Bhooshan Pandey
Kanti Bhooshan Pandey
SRSyed Ibrahim Rizvi
Syed Ibrahim Rizvi
Aging is an inevitable universal biological process, which can be characterized by a general decline in physiological function with the accumulation of diverse adverse changes and increased probability of death. Among several theories, oxidative stress/free radical theory offers the best mechanistic elucidation of the aging process and other age‐related phenomenon. In the present paper, we discuss the aging process and have focused on the importance of some reliable markers of oxidative stress which may be used as biomarkers of the aging process.

22 September 2016 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
ASAbhishek Kumar Singh
Abhishek Kumar Singh
MKMahendra Pratap Kashyap
Mahendra Pratap Kashyap
VTVinay Kumar Tripathi
Vinay Kumar Tripathi
SSSandeep Singh
Sandeep Singh
GGGeetika Garg
Geetika Garg
SRSyed Ibrahim Rizvi
Syed Ibrahim Rizvi

1 January 2018 in Life Sciences
Verified
Journal Article
Closed access
SSSandeep Singh
Sandeep Singh
ASAbhishek Kumar Singh
Abhishek Kumar Singh
GGGeetika Garg
Geetika Garg
SRSyed Ibrahim Rizvi
Syed Ibrahim Rizvi

1 June 2017 in Rejuvenation Research
Verified
Journal Article
Closed access
GGGeetika Garg
Geetika Garg
SSSandeep Singh
Sandeep Singh
ASAbhishek Kumar Singh
Abhishek Kumar Singh
SRSyed Ibrahim Rizvi
Syed Ibrahim Rizvi
Metformin, a biguanide, is a widely used antidiabetic drug, which inhibits gluconeogenesis and is used to treat hyperglycemia in type 2 diabetes. Through activation of AMPK (AMP-activated protein kinase) pathway, metformin also mimics caloric restriction health benefits. Aging causes substantial molecular to morphological changes in brain, the brain cells being more susceptible toward oxidative stress mediated damages due to the presence of high lipid content and higher oxygen consumption. Wistar rats (naturally aged and d -galactose induced rat model) were supplemented with metformin (300 mg/kg b.w. orally) for 6 weeks. The biomarkers of oxidative stress such as antioxidant capacity (ferric reducing antioxidant potential [FRAP]), malondialdehyde (MDA), reduced glutathione (GSH), protein carbonyl (PCO), reactive oxygen species (ROS), acetylcholinesterase (AChE) activity, and nitric oxide (NO) were measured in brain tissues of control and experimental groups. The results indicate that metformin treatment augmented the levels of FRAP and GSH in naturally aged, and d -gal induced aging model groups compared to the respective controls. In contrast, metformin treated groups exhibited significant reduction in MDA, PCO, ROS, and NO levels and a significant increase in AChE activity in induced aging rats. The administration of d -galactose upregulated the expression of sirtuin-2, interleukin-6 ( IL- 6), and tumor necrosis factor-alpha ( TNF-α ) and downregulated the expression of Beclin-1. Metformin supplementation downregulated the d -galactose induced expressions of sirtuin-2, IL -6, and TNF-α expression, whereas upregulated the Beclin-1 expression. Our data confirm that metformin restores the antioxidant status and improves healthy brain aging through the activation of autophagy and reduction in inflammation.